Olin (NYSE:OLN) Downgraded by Wall Street Zen to Sell

Wall Street Zen cut shares of Olin (NYSE:OLNFree Report) from a hold rating to a sell rating in a report published on Saturday.

Other analysts also recently issued reports about the company. Weiss Ratings reissued a “sell (d+)” rating on shares of Olin in a research report on Wednesday, October 8th. UBS Group lowered their price target on Olin from $24.00 to $22.00 and set a “neutral” rating for the company in a research report on Wednesday, October 29th. Citigroup decreased their target price on Olin from $23.00 to $21.00 and set a “neutral” rating on the stock in a research note on Thursday, December 18th. Truist Financial lowered their price objective on shares of Olin from $22.00 to $21.00 and set a “hold” rating for the company in a research note on Tuesday, October 28th. Finally, Mizuho set a $26.00 price target on shares of Olin in a research note on Friday, October 3rd. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $24.07.

Check Out Our Latest Report on Olin

Olin Stock Performance

Shares of OLN stock opened at $23.89 on Friday. The company has a market capitalization of $2.73 billion, a price-to-earnings ratio of 51.94, a price-to-earnings-growth ratio of 2.08 and a beta of 1.64. The company has a debt-to-equity ratio of 1.49, a quick ratio of 0.89 and a current ratio of 1.56. The company’s 50-day moving average is $20.61 and its 200 day moving average is $21.85. Olin has a one year low of $17.66 and a one year high of $34.76.

Olin (NYSE:OLNGet Free Report) last released its quarterly earnings data on Monday, October 27th. The specialty chemicals company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.09 by $0.31. Olin had a net margin of 0.79% and a return on equity of 3.36%. The business had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter in the prior year, the firm earned ($0.21) EPS. The business’s revenue was up 7.8% on a year-over-year basis. Sell-side analysts expect that Olin will post 1.38 EPS for the current fiscal year.

Olin Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, December 12th. Stockholders of record on Friday, November 28th were given a $0.20 dividend. The ex-dividend date of this dividend was Friday, November 28th. This represents a $0.80 annualized dividend and a dividend yield of 3.3%. Olin’s dividend payout ratio is presently 173.91%.

Insider Buying and Selling at Olin

In other Olin news, VP Teresa M. Vermillion sold 4,500 shares of the stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $20.86, for a total transaction of $93,870.00. Following the transaction, the vice president directly owned 17,199 shares in the company, valued at $358,771.14. This represents a 20.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Olin

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Strategic Advocates LLC acquired a new position in Olin in the 3rd quarter valued at $25,000. Evelyn Partners Investment Management LLP increased its holdings in Olin by 6,360.0% in the 2nd quarter. Evelyn Partners Investment Management LLP now owns 1,615 shares of the specialty chemicals company’s stock valued at $32,000 after buying an additional 1,590 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Olin during the 1st quarter worth approximately $32,000. Bessemer Group Inc. boosted its stake in Olin by 712.7% in the third quarter. Bessemer Group Inc. now owns 1,341 shares of the specialty chemicals company’s stock worth $34,000 after purchasing an additional 1,176 shares in the last quarter. Finally, UMB Bank n.a. grew its holdings in shares of Olin by 134.9% during the second quarter. UMB Bank n.a. now owns 1,736 shares of the specialty chemicals company’s stock worth $35,000 after purchasing an additional 997 shares during the last quarter. 88.67% of the stock is owned by institutional investors.

Olin News Roundup

Here are the key news stories impacting Olin this week:

Olin Company Profile

(Get Free Report)

Olin Corporation is a diversified manufacturer specializing in chemical products and ammunition. The company’s core business activities encompass the production and distribution of chlor-alkali products, epoxy resins and derivatives, and small-caliber ammunition under the Winchester brand. Olin’s chemical operations supply chlorine, caustic soda and related co-products to a wide range of end markets, including water treatment, pulp and paper, pharmaceuticals and general industrial applications.

In its Chlor Alkali Products & Vinyls segment, Olin operates multiple manufacturing facilities that produce chlorine and sodium hydroxide, along with vinyl chloride monomer and polyvinyl chloride (PVC) compounds.

Featured Articles

Analyst Recommendations for Olin (NYSE:OLN)

Receive News & Ratings for Olin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin and related companies with MarketBeat.com's FREE daily email newsletter.